Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1mecobalamin 1liposomal doxorubicin 1Urea 1Tobacco Use Cessation Devices 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Pyridoxine 1Pharmacokinetics 1Medicine, Chinese Traditional 1Low-Level Light Therapy 1Diclofenac 1Brimonidine Tartrate 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hand-Foot Syndrome × Celecoxib × Clear all
NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
11 enrolled 7 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡